Skip to main content
Michelle Alonso-Basanta, MD, Radiation Oncology, Philadelphia, PA

MichelleAlonso-BasantaMDPhD

Radiation Oncology Philadelphia, PA

Benign Diseases, Central Nervous System Cancer

Associate Professor, Vice Chair: Clinical Affairs, Chief: CNS Service, Department of Radiation Oncology, University of Pennsylvania, Perelman School of Medicine

Dr. Alonso-Basanta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alonso-Basanta's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd.
    Trc 2 West
    Philadelphia, PA 19104
    Phone+1 215-615-6767
    Fax+1 215-349-5545

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Radiation Oncology, 2004 - 2008
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Internal Medicine, 2003 - 2004
  • New York University School of Medicine
    New York University School of MedicineClass of 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2008 - 2025
  • NY State Medical License
    NY State Medical License 2004 - 2025
  • PA State Medical License
    PA State Medical License 2008 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Easing Patient Fears of Radiation Treatment, via Virtual Reality
    Easing Patient Fears of Radiation Treatment, via Virtual RealityOctober 24th, 2024
  • Penn Medicine Experts Offer Advice to the Next Generation of Innovators
    Penn Medicine Experts Offer Advice to the Next Generation of InnovatorsSeptember 7th, 2021